ATTR Cardiac Amyloidosis in a Selected Population
Recruiting
Observational Study
ATTR Amyloidosis Wild Type
ATTR Gene Mutation
Carpal Tunnel Syndrome
Cardiac Amyloidosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 50 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 180 (estimated)
- Sponsor
- Helse Møre og Romsdal HF · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male \> 50 years
* Female \> 60 years
* operated CTS at Ålesund Hospital
Exclusion Criteria:
* not consented
* do not speak Norwegian
* secondary cause of CTS as traumatic or rheumatic
* cannot be followed \> 5 years due to other medical conditions
* Cardiac disease at time …
Contacts